Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01730768
Show Display Options
Rank Status Study
1 Completed A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients
Condition: Schizophrenia
Interventions: Drug: AQW051;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.